Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Rejoyn becomes first prescription-only app for depression in Great Britain with its mode of action

    Clinically validated digital therapeutic launches with UKCA mark and NHS [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development

    Faction imaging secures $10M to reinvent AI-native medical imaging infrastructure

    Backed by Nodenza Venture Partners, the stealth-mode innovator emerges with [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?

    Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

    May 5, 2026
  • Clinical & Regulatory,Manufacturing & Supply Chain

    Tjoapack Q&A: Why serialisation is now a strategic advantage in pharma

    Discover Pharma speaks with Max van Heeswijk, IT Manager at [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Advarra launches industry council to guide responsible AI use in clinical trials

    A new industry council aims to shape best practices for [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development

    Oral hope for diabetic retinopathy: Breye completes positive Phase 1b trial of danegaptide

    Breye Therapeutics has announced the successful completion of its Phase [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    $200M market in sight as Nutriband and Kindeva scale up abuse-deterrent fentanyl patch

    Milestone achieved for Aversa Fentanyl, a transdermal patch combining proven [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    Live biotherapeutics face growing pains as clinical activity rises

    A new white paper from contract research organisation Novotech has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data

    FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development

    Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    UK experts urge Government to appoint Minister for cell and gene therapies

    Commission sets out 25 policy recommendations to unlock access and [...]

    May 5, 2026
Previous697071Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CHMP recommends approval of NEZGLYAL for rare neurodegenerative disease
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Aravind and Alcon launch global retina surgery training centre in India
    Categories: Medical devices, Research & Development
  • Atsena receives EMA orphan designation for two inherited retinal disease gene therapies
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top